Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 541 to 550 of 2494

TitleReference numberPublishedLast updated
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrenceTA817
Stockholm3 for prostate cancer screeningMIB303
Bioresorbable stent implantation to treat coronary artery diseaseIPG732
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissectionIPG733
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitisTA814
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancerTA812
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitorsTA813
PLGF-based testing to help diagnose suspected preterm pre-eclampsiaDG49
Transcatheter tricuspid valve annuloplasty for tricuspid regurgitationIPG730

Results per page

  1. 10
  2. 25
  3. 50
  4. All